These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 25918835
21. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC). Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS. Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904 [Abstract] [Full Text] [Related]
24. A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast. Byun BH, Noh WC, Lim I, Lee SS, Cho AR, Park JA, Kim KM, Kim HA, Kim EK, Kim BI, Choi CW, Lim SM. Ann Nucl Med; 2013 Oct; 27(8):720-8. PubMed ID: 23700260 [Abstract] [Full Text] [Related]
30. Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors. Nakajo M, Nakajo M, Fukukura Y, Jinguji M, Shindo T, Nakabeppu Y, Kamimura K, Yoneyama T, Takumi K, Yoshiura T. Abdom Imaging; 2015 Aug; 40(6):1655-65. PubMed ID: 25382022 [Abstract] [Full Text] [Related]
31. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H. Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992 [Abstract] [Full Text] [Related]
33. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography. Tsuchida T, Morikawa M, Demura Y, Umeda Y, Okazawa H, Kimura H. J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463 [Abstract] [Full Text] [Related]
34. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI. Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y. Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862 [Abstract] [Full Text] [Related]
35. Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values. Lee SY, Jee WH, Yoo IR, Jung JY, Im SA, Chung YG, Kang JH. Br J Radiol; 2019 Oct; 92(1102):20181051. PubMed ID: 31322913 [Abstract] [Full Text] [Related]
36. Diagnostic value of 18F-FDG PET/CT versus diffusion-weighted MRI in detection of residual or recurrent tumors after definitive (chemo) radiotherapy for laryngeal and hypopharyngeal squamous cell carcinoma: A prospective study. Kim SY, Crook D, Rosskopf J, Lee JH. Head Neck; 2024 Sep; 46(9):2284-2291. PubMed ID: 38712471 [Abstract] [Full Text] [Related]
40. Comparison of diffusion-weighted MR imaging and 18F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma. Schroeder C, Lee JH, Tetzner U, Seidel S, Kim SY. Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]